Hematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationGraft vs Host DiseaseLeukemia, Myeloid, AcuteTransplantation ConditioningStem CellsLeukemia, MyeloidHematologic NeoplasmsPeripheral Blood Stem Cell TransplantationTransplantation, AutologousLeukemiaTransplantation ChimeraRemission InductionBone Marrow TransplantationGraft vs Leukemia EffectTreatment OutcomeTissue DonorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRecurrenceHematopoietic Stem CellsMyeloablative AgonistsVidarabineHistocompatibilityBusulfanHistocompatibility TestingAcute DiseaseMyelodysplastic SyndromesGraft SurvivalLymphocyte TransfusionGraft vs Tumor EffectPrecursor Cell Lymphoblastic Leukemia-LymphomaCytarabineDisease-Free SurvivalCord Blood Stem Cell TransplantationLymphocyte DepletionImmunosuppressive AgentsSiblingsRetrospective StudiesEmbryonic Stem CellsSurvival RateWhole-Body IrradiationSurvival AnalysisNeoplasm, ResidualCombined Modality TherapyMultiple Myelomafms-Like Tyrosine Kinase 3Antilymphocyte SerumAdult Stem CellsSalvage TherapyAntineoplastic Combined Chemotherapy ProtocolsHLA AntigensAntigens, CD34Mesenchymal Stem Cell TransplantationCytomegalovirus InfectionsMinor Histocompatibility AntigensPrognosisT-LymphocytesCell DifferentiationAntineoplastic AgentsTime FactorsFusion Proteins, bcr-ablLiver TransplantationBenzamidesCyclophosphamideHematopoietic Stem Cell MobilizationVirus ActivationCytogenetic AnalysisMelphalanPluripotent Stem CellsLeukemia, Lymphocytic, Chronic, B-CellPyrimidinesBlast CrisisChimerismGene Expression Regulation, LeukemicHepatic Veno-Occlusive DiseaseFollow-Up StudiesBone MarrowPiperazinesLeukemia, Myeloid, Accelerated PhaseGranulocyte Colony-Stimulating FactorStem Cell NichePrimary MyelofibrosisFlow CytometryBone Marrow CellsCytomegalovirusNeural Stem CellsCell TransplantationAnemia, AplasticHematologic DiseasesSevere Combined ImmunodeficiencyInduced Pluripotent Stem CellsLeukemia, Myelomonocytic, AcuteMesenchymal Stromal CellsKidney TransplantationImmunophenotypingImmunotherapy, AdoptiveAntibodies, NeoplasmDaunorubicinCells, Cultured